124 related articles for article (PubMed ID: 16169716)
21. Extensive posttreatment ganglioneuromatous differentiation of rhabdomyosarcoma: malignant ectomesenchymoma in an infant.
Sebire NJ; Ramsay AD; Malone M; Risdon RA
Pediatr Dev Pathol; 2003; 6(1):94-6. PubMed ID: 12469232
[No Abstract] [Full Text] [Related]
22. Minimal residual marrow disease: detection and significance of isolated tumour cells in bone marrow.
Iorgulescu DG; Kiroff GK
ANZ J Surg; 2001 Jun; 71(6):365-76. PubMed ID: 11409023
[TBL] [Abstract][Full Text] [Related]
23. Disseminated tumor cells of breast cancer patients: a strong prognostic factor for distant and local relapse.
Bidard FC; Vincent-Salomon A; Gomme S; Nos C; de Rycke Y; Thiery JP; Sigal-Zafrani B; Mignot L; Sastre-Garau X; Pierga JY;
Clin Cancer Res; 2008 Jun; 14(11):3306-11. PubMed ID: 18519757
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.
Gaynon PS; Harris RE; Altman AJ; Bostrom BC; Breneman JC; Hawks R; Steele D; Zipf T; Stram DO; Villaluna D; Trigg ME
J Clin Oncol; 2006 Jul; 24(19):3150-6. PubMed ID: 16717292
[TBL] [Abstract][Full Text] [Related]
25. Occult bone marrow involvement in patients with diffuse large B-cell lymphoma: results of a pilot study.
Talaulikar D; Dahlstrom JE; Shadbolt B; McNiven M; Broomfield A; Pidcock M
Pathology; 2007 Dec; 39(6):580-5. PubMed ID: 18027262
[TBL] [Abstract][Full Text] [Related]
26. Prognostic relevance of disseminated tumor cells in the bone marrow and biological factors of 265 primary breast carcinomas.
Schindlbeck C; Kampik T; Janni W; Rack B; Jeschke U; Krajewski S; Sommer H; Friese K
Breast Cancer Res; 2005; 7(6):R1174-85. PubMed ID: 16457698
[TBL] [Abstract][Full Text] [Related]
27. Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy.
Ribrag V; Vanel D; Leboulleux S; Lumbroso J; Couanet D; Bonniaud G; Aupérin A; Masson F; Bosq J; Edeline V; Fermé C; Pigneur F; Schlumberger M
Eur J Radiol; 2008 May; 66(2):325-31. PubMed ID: 17651934
[TBL] [Abstract][Full Text] [Related]
28. Prognostic relevance of disseminated tumour cells in bone marrow of patients with transitional cell carcinoma.
Hofmann T; Buchner A; Hofstetter A; Stief CG; Oberneder R; Riesenberg R
Eur J Cancer; 2007 Dec; 43(18):2678-84. PubMed ID: 17977715
[TBL] [Abstract][Full Text] [Related]
29. Detection of the MyoD1 transcript in rhabdomyosarcoma cell lines and tumor samples by reverse transcription polymerase chain reaction.
Frascella E; Rosolen A
Am J Pathol; 1998 Feb; 152(2):577-83. PubMed ID: 9466584
[TBL] [Abstract][Full Text] [Related]
30. Clinical outcome of gastric cancer patients with bone marrow metastases.
Kim HS; Yi SY; Jun HJ; Lee J; Park JO; Park YS; Jang J; Kim HJ; Ko Y; Lim HY; Kang WK
Oncology; 2007; 73(3-4):192-7. PubMed ID: 18418012
[TBL] [Abstract][Full Text] [Related]
31. [Localised rhabdomyosarcoma of the extremities in children and adolescents: results of the French experience].
Diepold M; Rey A; Oberlin O; Boulay N; Bergeron C; Glorion C; Mary P; Terrier-Lacombe MJ; Helfre S; Habrand JL; Gentet JC; Defachelles AS; Thomas C; Brisse H; Pierron G; Orbach D
Bull Cancer; 2008 Nov; 95(11):1021-8. PubMed ID: 19036673
[TBL] [Abstract][Full Text] [Related]
32. The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement.
Campbell J; Seymour JF; Matthews J; Wolf M; Stone J; Juneja S
Eur J Haematol; 2006 Jun; 76(6):473-80. PubMed ID: 16529599
[TBL] [Abstract][Full Text] [Related]
33. Flow cytometric phenotype of rhabdomyosarcoma bone marrow metastatic cells and its implication in differential diagnosis with neuroblastoma.
Bozzi F; Collini P; Aiello A; Barzanò E; Gambirasio F; Podda M; Meazza C; Ferrari A; Luksch R
Anticancer Res; 2008; 28(3A):1565-9. PubMed ID: 18630512
[TBL] [Abstract][Full Text] [Related]
34. Frequency and prognostic relevance of disseminated tumor cells in bone marrow of patients with metastatic renal cell carcinoma.
Buchner A; Riesenberg R; Kotter I; Hofstetter A; Stief C; Oberneder R
Cancer; 2006 Apr; 106(7):1514-20. PubMed ID: 16518813
[TBL] [Abstract][Full Text] [Related]
35. Molecular detection of disseminated breast cancer cells in the bone marrow of early breast cancer patients using quantitative RT PCR for CEA.
Janku F; Srovnal J; Korinkova G; Novotny J; Petruzelka L; Power D; Matous B; Hajduch M
Neoplasma; 2008; 55(4):317-22. PubMed ID: 18505343
[TBL] [Abstract][Full Text] [Related]
36. Matrix metalloproteinase-13 expression is associated with bone marrow microinvolvement and prognosis in non-small cell lung cancer.
Hsu CP; Shen GH; Ko JL
Lung Cancer; 2006 Jun; 52(3):349-57. PubMed ID: 16569461
[TBL] [Abstract][Full Text] [Related]
37. Rhabdomyosarcoma of the urinary bladder in adults: predilection for alveolar morphology with anaplasia and significant morphologic overlap with small cell carcinoma.
Paner GP; McKenney JK; Epstein JI; Amin MB
Am J Surg Pathol; 2008 Jul; 32(7):1022-8. PubMed ID: 18469707
[TBL] [Abstract][Full Text] [Related]
38. Prognostic significance of immunohistochemical expression of ezrin in non-metastatic high-grade osteosarcoma.
Ferrari S; Zanella L; Alberghini M; Palmerini E; Staals E; Bacchini P
Pediatr Blood Cancer; 2008 Apr; 50(4):752-6. PubMed ID: 17886294
[TBL] [Abstract][Full Text] [Related]
39. Prognostic influence of minimal residual disease detected by flow cytometry and peripheral blood stem cell transplantation by CD34+ selection in childhood advanced neuroblastoma.
Cai JY; Tang YJ; Jiang LM; Pan C; Chen J; Tang JY
Pediatr Blood Cancer; 2007 Dec; 49(7):952-7. PubMed ID: 17514736
[TBL] [Abstract][Full Text] [Related]
40. Does the time-point of relapse influence outcome in pediatric rhabdomyosarcomas?
Mattke AC; Bailey EJ; Schuck A; Dantonello T; Leuschner I; Klingebiel T; Treuner J; Koscielniak E
Pediatr Blood Cancer; 2009 Jul; 52(7):772-6. PubMed ID: 19165889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]